Market News

Wendell David Associates Trimmed Its Cvs Health (CVS) Stake; Ameriserv Financial (ASRV)’s Sentiment Is 2

Wendell David Associates Inc decreased Cvs Health (CVS) stake by 21.67% reported in 2017Q3 SEC filing. Wendell David Associates Inc sold 6,915 shares as Cvs Health (CVS)’s stock declined 4.23%. The Wendell David Associates Inc holds 25,000 shares with $2.03M value, down from 31,915 last quarter. Cvs Health now has $80.39 billion valuation. The stock decreased 0.19% or $0.15 during the last trading session, reaching $79.35. About 8.07M shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since January 19, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

AmeriServ Financial, Inc. operates as a bank holding firm for the AmeriServ Financial Bank that provides various consumer, mortgage, and commercial financial products. The company has market cap of $74.01 million. It offers retail banking services, such as demand, savings, and time deposits; checking and money market accounts; secured and unsecured consumer loans, and mortgage loans; safe deposit boxes, holiday club accounts, money orders, and travelerÂ’s checks. It has a 13.97 P/E ratio. The firm also provides lending, depository, and related financial services, such as commercial real estate mortgage loans, short and medium-term loans, revolving credit arrangements, lines of credit, inventory and accounts receivable financing, real estate-construction loans, business savings accounts, certificates of deposit, wire transfers, night depository, and lock box services to commercial, industrial, financial, and governmental customers.

Since January 1, 0001, it had 0 insider buys, and 2 selling transactions for $164,320 activity.

It closed at $4.05 lastly. It is down 32.45% since January 19, 2017 and is uptrending. It has outperformed by 15.75% the S&P500.

Oppenheimer & Close Llc holds 0.46% of its portfolio in AmeriServ Financial, Inc. for 110,040 shares. Lesa Sroufe & Co owns 100,000 shares or 0.35% of their US portfolio. Moreover, Pinnacle Holdings Llc has 0.28% invested in the company for 186,773 shares. The Pennsylvania-based Minerva Advisors Llc has invested 0.27% in the stock. Gendell Jeffrey L, a Connecticut-based fund reported 307,018 shares.

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 66 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Buy” rating by Argus Research given on Monday, August 10. Morgan Stanley upgraded CVS Health Corporation (NYSE:CVS) on Friday, January 5 to “Overweight” rating. The firm earned “Outperform” rating on Monday, November 2 by Oppenheimer. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Wolfe Research on Wednesday, August 16. On Wednesday, August 16 the stock rating was maintained by Jefferies with “Hold”. Oppenheimer maintained CVS Health Corporation (NYSE:CVS) on Friday, August 28 with “Outperform” rating. The rating was maintained by Deutsche Bank on Thursday, August 20 with “Hold”. The rating was maintained by RBC Capital Markets with “Outperform” on Wednesday, August 5. Citigroup maintained it with “Neutral” rating and $115 target in Monday, May 9 report. Robert W. Baird initiated CVS Health Corporation (NYSE:CVS) rating on Friday, January 22. Robert W. Baird has “Outperform” rating and $108 target.

Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It turned negative, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. 8,155 were reported by Old Dominion Capital Mngmt Inc. Coho Prns Limited accumulated 2.15 million shares or 4.49% of the stock. Horan Cap Mngmt holds 1.98% or 117,113 shares. Hyman Charles D has 2,850 shares for 0.03% of their portfolio. Jnba Advisors reported 5,999 shares. Segall Bryant And Hamill Limited Co reported 11,986 shares. Hills Bankshares Co holds 45,236 shares or 1.15% of its portfolio. Winfield Associate has 0.16% invested in CVS Health Corporation (NYSE:CVS) for 3,835 shares. Mitchell Mcleod Pugh And Williams reported 6,283 shares or 0.38% of all its holdings. First Bank & Trust Of Mount Dora Tru Investment Services invested in 39,390 shares or 1.58% of the stock. Smith Salley And Assocs has 57,008 shares for 0.89% of their portfolio. Hancock Hldg Com has 0.09% invested in CVS Health Corporation (NYSE:CVS). Ariel Invs Ltd Liability Corporation holds 0.11% or 115,894 shares in its portfolio. Westchester Cap holds 3.64% or 104,375 shares in its portfolio. Caxton Associate Limited Partnership invested 0.01% in CVS Health Corporation (NYSE:CVS).

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on February, 8. They expect $1.90 earnings per share, up 11.11% or $0.19 from last year’s $1.71 per share. CVS’s profit will be $1.92 billion for 10.44 P/E if the $1.90 EPS becomes a reality. After $1.50 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 26.67% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *